BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33742398)

  • 1. Real-Time Cell Migration Monitoring to Analyze Drug Synergism in the Scratch Assay Using the IncuCyte System.
    Kobelt D; Walther W; Stein US
    Methods Mol Biol; 2021; 2294():133-142. PubMed ID: 33742398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous biphasic cancer cell migration assay enables robust, high-throughput screening of anti-cancer compounds.
    Lemmo S; Nasrollahi S; Tavana H
    Biotechnol J; 2014 Mar; 9(3):426-34. PubMed ID: 24265131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor spheroid-based migration assays for evaluation of therapeutic agents.
    Vinci M; Box C; Zimmermann M; Eccles SA
    Methods Mol Biol; 2013; 986():253-66. PubMed ID: 23436417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for High-throughput Drug Combination Screening and Synergy Scoring.
    He L; Kulesskiy E; Saarela J; Turunen L; Wennerberg K; Aittokallio T; Tang J
    Methods Mol Biol; 2018; 1711():351-398. PubMed ID: 29344898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the Wound Scratch Assay to Detect Changes in Murine Mesenchymal Stromal Cell Migration After Damage by Soluble Cigarette Smoke Extract.
    Cormier N; Yeo A; Fiorentino E; Paxson J
    J Vis Exp; 2015 Dec; (106):e53414. PubMed ID: 26709527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Analytical Platform For Robust Identification of Cell Migration Inhibitors.
    Somchai P; Phongkitkarun K; Kueanjinda P; Jamnongsong S; Vaeteewoottacharn K; Luvira V; Okada S; Jirawatnotai S; Sampattavanich S
    Sci Rep; 2020 Jan; 10(1):931. PubMed ID: 31969633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tapered microtract array platform for antimigratory drug screening of human glioblastoma multiforme.
    Cha J; Koh I; Choi Y; Lee J; Choi C; Kim P
    Adv Healthc Mater; 2015 Feb; 4(3):405-11. PubMed ID: 25230171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the activities of actin-affecting drugs on tumor cell migration.
    Hayot C; Debeir O; Van Ham P; Van Damme M; Kiss R; Decaestecker C
    Toxicol Appl Pharmacol; 2006 Feb; 211(1):30-40. PubMed ID: 16005926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directional Collective Migration in Wound Healing Assays.
    Molinie N; Gautreau A
    Methods Mol Biol; 2018; 1749():11-19. PubMed ID: 29525986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. qCMA: a desktop application for quantitative collective cell migration analysis.
    Zeisel A; Yitzhaky A; Koerner C; Lauriola M; Cohen-Dvashi H; Köstler WJ; Yarden Y; Wiemann S; Domany E
    J Biomol Screen; 2013 Mar; 18(3):356-60. PubMed ID: 23042078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards an Endpoint Cell Motility Assay by a Microfluidic Platform.
    Yeh CF; Tai W; Lin CH; Juang DS; Wu CC; Chen YW; Hsu CH
    IEEE Trans Nanobioscience; 2015 Dec; 14(8):835-40. PubMed ID: 26415207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal-mode migration assay and antimetastatic drug screening with high-throughput microfluidic channel networks.
    Zhang Y; Zhang W; Qin L
    Angew Chem Int Ed Engl; 2014 Feb; 53(9):2344-8. PubMed ID: 24478127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating cell diffusivity and cell proliferation rate by interpreting IncuCyte ZOOM™ assay data using the Fisher-Kolmogorov model.
    Johnston ST; Shah ET; Chopin LK; Sean McElwain DL; Simpson MJ
    BMC Syst Biol; 2015 Jul; 9():38. PubMed ID: 26188761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can anti-migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration.
    Decaestecker C; Debeir O; Van Ham P; Kiss R
    Med Res Rev; 2007 Mar; 27(2):149-76. PubMed ID: 16888756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative, facile, and high-throughput image-based cell migration method is a robust alternative to the scratch assay.
    Gough W; Hulkower KI; Lynch R; McGlynn P; Uhlik M; Yan L; Lee JA
    J Biomol Screen; 2011 Feb; 16(2):155-63. PubMed ID: 21297103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrete and Continuum Approximations for Collective Cell Migration in a Scratch Assay with Cell Size Dynamics.
    Matsiaka OM; Penington CJ; Baker RE; Simpson MJ
    Bull Math Biol; 2018 Apr; 80(4):738-757. PubMed ID: 29372496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking the Potential of High-Throughput Drug Combination Assays Using Acoustic Dispensing.
    Chan GK; Wilson S; Schmidt S; Moffat JG
    J Lab Autom; 2016 Feb; 21(1):125-32. PubMed ID: 26160862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
    Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
    BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis.
    Varbanov HP; Kuttler F; Banfi D; Turcatti G; Dyson PJ
    PLoS One; 2019; 14(1):e0211268. PubMed ID: 30695050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of fluorescence imaging based assay for screening compounds with anti-migration activity].
    Nie XJ; Zhao XP; Wang Y
    Yao Xue Xue Bao; 2011 Jul; 46(7):793-7. PubMed ID: 22010348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.